Study links Edwards' transcatheter heart valve to higher survival rate

09/22/2010 | Washington Post, The

A study of 358 patients who need heart valve replacements but are not candidates for open-heart surgery showed that 30% of those who were implanted with Edwards Lifesciences' transcatheter aortic valve died a year after, compared with half of those who didn't receive the device. However, the study showed that valve recipients were more likely to have strokes than those who didn't get the device.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI